Abstract
Background - Salmeterol and formoterol have a lower intrinsic activity at β2 receptors than isoprenaline in human bronchus in vitro. The aim of the present study was to evaluate in vivo the p, agonist/antagonist activity of salmeterol and formoterol at rest with low endogenous adrenergic tone, on exercise with raised endogenous adrenergic tone, and in the presence of fenoterol, an exogenous full β2 receptor agonist. Methods - Eight normal subjects were randomised to receive single doses of placebo, salmeterol 300 μg, formoterol 72 μg, or propranolol 80 mg at weekly intervals. β2 adrenoceptor responses were evaluated at rest, at peak exercise, and after treatment with fenoterol 2.4 mg. Results - At rest salmeterol and formoterol exhibited equivalent β2 agonist activity with regard to decrease in serum potassium levels and increase in finger tremor, with propranolol having no effect. Salmeterol and formoterol, like propranolol, potentiated the hyperkalaemic delta response to exercise compared with placebo, consistent with β2 antagonism: (mean difference and 95% confidence interval (CI) compared with placebo) salmeterol 0.20 (0.02 to 0.38) mmol/l, formoterol 0.17 (0.00 to 0.34) mmol/l, propranolol 0.45 (0.08 to 0.82) mmol/l. Propranolol blunted the heart rate delta response to exercise, consistent with β1 blockade, whilst salmeterol and formoterol had no effect. Salmeterol and formoterol, like propranolol, attenuated the hypokalaemic, tremor, and heart rate delta responses to fenoterol compared with placebo, in keeping with β2 blockade: potassium, salmeterol 0.18 (0.0 to 0.36) mmol/l, formoterol 0.17 (-0.03 to 0.37) mmol/l, propranolol 0.80 (0.54 to 1.06) mmol/l; tremor, salmeterol -0.69 (-1.26 to -0.12) log units, formoterol -0.71 (-1.53 to 0.11) log units, propranolol -0.85 (-1.66 to -0.04) log units; heart rate, salmeterol -6 (-13 to 1) beats/min, formoterol -10 (-19 to -1) beats/min, propranolol -18 (-29 to -7) beats/min. Conclusions - At rest with low endogenous adrenergic tone salmeterol and formoterol showed equivalent β2 mediated agonist activity in terms of serum potassium and finger tremor responses. In the presence of raised endogenous adrenergic tone at peak exercise and in the presence of fenoterol (an exogenous full β2 receptor agonist), salmeterol and formoterol, like propranolol, exhibited β2 receptor antagonism as evidenced by their attenuation of β2 receptor mediated responses. The degree of β2 blockade with formoterol and salmeterol was comparable but less than with propranolol. The relevance of these findings at extrapulmonary β2 receptors with regard to airway β2 responses remains unclear and warrants further investigation.
Author supplied keywords
Cite
CITATION STYLE
Grove, A., & Lipworth, B. J. (1996). Evaluation of the β2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol. Thorax, 51(1), 54–58. https://doi.org/10.1136/thx.51.1.54
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.